For instance, ARHGAP45 inhibition could enhance the effects of other immunotherapies such as immune checkpoint inhibitors, by improving the immune system’s ability to recognize and destroy tumors by reducing the invasiveness of tumor cells. Here, ARHGAP45 is linked to neoplasm.